102
Views
4
CrossRef citations to date
0
Altmetric
Miscellaneous

Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?

Pages 205-208 | Published online: 02 Mar 2005

Bibliography

  • POOLE-WILSON PA, SWEDBERG K, CLELAND JGF et al.: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET); randomised controlled trial. Lancet (2003) 362:7–13.
  • STEWART S, MACINTYRE K, HOLE DJ, CAPE WELL S, MCMURRAY JJV: More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Heart Fall. (2001) 3:315–322.
  • PACKER M, BRISTOW MR, COHN JNet al.: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl. J. Med. (1996) 334:1349–1355.
  • PACKER M, COATS AJ, FOWLER MRet al.: Effect of carvedilol on survival in severe chronic heart failure. N Engl. I Med. (2001) 344:1651–1658.
  • WAAGSTEIN R, BRISTOW MR, SWEDBERG K et al.: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet (1993) 342:1441–1446.
  • THE MERIT-HF INVESTIGATORS: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet (1999) 353:2001–2007.
  • GOLDSTEIN S, FAGERBERG B, HJAALMARSON A et al.: Metoprolol controlled release/extended release in patients with severe heart failure. I Am. Cardiol. (2001) 38:932–938.
  • GILBERT EM, ABRAHAM WT, OLSEN S et al: Comparative hemodynamic, left ventricular functional, and anti-adrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation (1996) 94:2817–2825.
  • SANDERSON JE, CHAN SK, YIP G et al.: Beta-blockade in heart failure: a comparison of carvedilol with metoprolol. J. Am. Coll Cardiol. (1999) 34:1522–1528.
  • METRA M, GIUBBINI R, NODARI S et al.: Differential effects of I3-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation (2000) 102:546–551.
  • DI LENARDA A, SABBADINI G, SALVATORE L et al.: Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. jAm. Coll Cardiol. (1999) 33:1926–1934.
  • THE INTERNATIONAL STEERING COMMITTEE: Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). Am. j Cardiol. (1997) 80:54J–58J.
  • WIKSTRAND J, HJALMARSON A, WAAGSTEIN F et al.: Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). J. Am. Coll. Cardiol. (2002) 7:491–498.
  • DARGIE HJ: Beta blockers in heart failure. Lancet (2003) 362:2–3.
  • SANDBERG A, BLOMQVIST I, JONSSON UE, LUNDBORG P: Parmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets. Eur: j Clin. Pharmacy]. (1988) 33(Suppl.):S9–S14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.